Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon, marking a new era of […]
Pakistan blast: How did we get here?
With the death toll for the most recent suicide bombing climbing past 50 in Pakistan, the head of Jamiat Ulema Islam (JUI-F) party, whose supporters were targeted in the blast, decried the country’s security forces over the apparent “intelligence failu…
Digital Payments Leader Visa Eyes Regional Expansion, Officially Opens New Pakistan Office
Visa (NYSE:V), the world’s digital payments leader has officially inaugurated its new office in Pakistan.Visa’s expanded on-ground presence in Pakistan is a testament to its commitment to supporting the company’s financial institution and merchant cli…
SIFC to Ensure Ease of Doing Business for Investors: COAS
Chief of Army Staff (COAS), General Syed Asim Munir Tuesday said the government, along with state institutions, had ensured the establishment of the Special Investment Facilitation Council (SIFC), to bring the stakeholders on one platform.According to…